Nissui Pharmaceutical Co., Ltd. announced consolidated earnings results for the nine months ended December 31, 2018. For the period, net sales were JPY 9,234 million compared to JPY 9,143 million a year ago. Operating profit was JPY 940 million compared to JPY 991 million a year ago. Ordinary profit was JPY 990 million compared to JPY 1,074 million a year ago. Profit attributable to owners of parent was JPY 463 million compared to JPY 872 million a year ago. Earnings per share were JPY 20.70 compared to JPY 38.98 a year ago.

For the year ending March 31, 2019, the company expects net sales of JPY 13,000 million, operating income of JPY 1,550 million, ordinary profit of JPY 1,570 million, profit attributable to owners of parent of JPY 860 million and earnings per share of JPY 38.40.